Active Pharmaceutical Ingredients (API) Market 2021| Global Leading Players, Industry Updates, Future Growth, Business Prospects, Forthcoming Developments And Future Investments By Forecast To 2027 | Teva, Mylan, DSM

Market Summary

A newly published report titled “(Active Pharmaceutical Ingredients (API) Market)” by QY Research throws light on the industry dynamics and current and future trends that play a key role in determining the business expansion. The report also highlights the key driving factors and restraints that are impacting the growth. For a comprehensive understanding, the professionals have reviewed the regulatory scenario, market entry strategies, best industry practices, pricing strategy, technology landscape, and consumption, sales, and demand outlook. Y-o-Y growth estimates have also been included to provide the users with accurate statistics and facts. This report will give the readers a bigger and see-through picture of the overall scenario.

Covid-19 Impact Outlook

This section of the report reveals the consequence of the covid pandemic on business, globally. Effect on manufacturing activities, production, demand, supply chain and logistics management, and distribution networks has been exposed in this report. The analysts have pointed out the measures or strategies that the companies are taking up to fight the covid-19 impact. Moreover, they have identified key opportunities that are emerging post-COVID-19. This will help the players capitalize on the opportunities to recover losses and stabilize their businesses

Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart) https://www.qyresearch.com/sample-form/form/4111066/global-active-pharmaceutical-ingredients-api-market

In addition, market revenues based on region and country are provided in the Active Pharmaceutical Ingredients (API) report. The authors of the report have also shed light on the common business tactics adopted by players. The leading players of the global Active Pharmaceutical Ingredients (API) market and their complete profiles are included in the report. Besides that, investment opportunities, recommendations, and trends that are trending at present in the global Active Pharmaceutical Ingredients (API) market are mapped by the report. With the help of this report, the key players of the global Active Pharmaceutical Ingredients (API) market will be able to make sound decisions and plan their strategies accordingly to stay ahead of the curve.

Competitive landscape is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the global Active Pharmaceutical Ingredients (API) market to know the competition at both the domestic and global levels. Market experts have also offered the outline of every leading player of the global Active Pharmaceutical Ingredients (API) market, considering the key aspects such as areas of operation, production, and product portfolio. Additionally, companies in the report are studied based on the key factors such as company size, market share, market growth, revenue, production volume, and profits.

Key Players Mentioned:
Teva, Mylan, DSM, Aurobindo Pharma, Aspen, Novartis, BASF, Pfizer, Huahai Pharmaceutical, Hisun Pharmaceutical, Sun Pharmaceutical Industries, Zhejiang Medicine, Dr. Reddy’s Laboratories, Zhejiang NHU, Bayer, NCPC, AbbVie, Shandong Xinhua Pharmaceutical, Northeast Pharm, Harbin Pharmaceutical, LKPC

Market Segmentation by Product:
Synthetic APIs
Biotech APIs

Market Segmentation by Application:
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others

The Active Pharmaceutical Ingredients (API) Market report has been segregated based on distinct categories, such as product type, application, end user, and region. Each and every segment is evaluated on the basis of CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is estimated to generate opportunities in the global Active Pharmaceutical Ingredients (API) market in the forthcoming years. This segmental analysis will surely turn out to be a useful tool for the readers, stakeholders, and market participants to get a complete picture of the global Active Pharmaceutical Ingredients (API) market and its potential to grow in the years to come.

Request for customization in Report: https://www.qyresearch.com/customize-request/form/4111066/global-active-pharmaceutical-ingredients-api-market

Frequently Asked Questions

At what growth rate is the application segment expected to expand?
Which factors will lead to the Active Pharmaceutical Ingredients (API) market expansion?
What will be the global Active Pharmaceutical Ingredients (API) market size by 2028?
What are the key constraints in the Active Pharmaceutical Ingredients (API) market growth?
Which type segment will witness healthy growth from xx to xx?
Which region presents lucrative growth prospects?
Which companies are the key innovators in the Active Pharmaceutical Ingredients (API) market?
What are the key business strategies for post-covid recovery?
Who are the key leaders in the global Active Pharmaceutical Ingredients (API) market?
Which technological advancements will influence the Active Pharmaceutical Ingredients (API) market growth?

Table of Contents:

1 Active Pharmaceutical Ingredients (API) Market Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients (API)
1.2 Active Pharmaceutical Ingredients (API) Segment by Type
1.2.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate Analysis by Type 2021 VS 2027
1.2.2 Synthetic APIs
1.2.3 Biotech APIs
1.3 Active Pharmaceutical Ingredients (API) Segment by Application
1.3.1 Global Active Pharmaceutical Ingredients (API) Consumption Comparison by Application: 2016 VS 2021 VS 2027
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Global Market Growth Prospects
1.4.1 Global Active Pharmaceutical Ingredients (API) Revenue Estimates and Forecasts (2016-2027)
1.4.2 Global Active Pharmaceutical Ingredients (API) Production Capacity Estimates and Forecasts (2016-2027)
1.4.3 Global Active Pharmaceutical Ingredients (API) Production Estimates and Forecasts (2016-2027)
1.5 Global Market Size by Region
1.5.1 Global Active Pharmaceutical Ingredients (API) Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
1.5.2 North America Active Pharmaceutical Ingredients (API) Estimates and Forecasts (2016-2027)
1.5.3 Europe Active Pharmaceutical Ingredients (API) Estimates and Forecasts (2016-2027)
1.5.4 China Active Pharmaceutical Ingredients (API) Estimates and Forecasts (2016-2027)
1.5.5 Japan Active Pharmaceutical Ingredients (API) Estimates and Forecasts (2016-2027)
1.5.6 India Active Pharmaceutical Ingredients (API) Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers
2.1 Global Active Pharmaceutical Ingredients (API) Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturers (2016-2021)
2.3 Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2016-2021)
2.5 Manufacturers Active Pharmaceutical Ingredients (API) Production Sites, Area Served, Product Types
2.6 Active Pharmaceutical Ingredients (API) Market Competitive Situation and Trends
2.6.1 Active Pharmaceutical Ingredients (API) Market Concentration Rate
2.6.2 Global 5 and 10 Largest Active Pharmaceutical Ingredients (API) Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region
3.1 Global Production Capacity of Active Pharmaceutical Ingredients (API) Market Share by Region (2016-2021)
3.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2016-2021)
3.3 Global Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 North America Active Pharmaceutical Ingredients (API) Production
3.4.1 North America Active Pharmaceutical Ingredients (API) Production Growth Rate (2016-2021)
3.4.2 North America Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Active Pharmaceutical Ingredients (API) Production
3.5.1 Europe Active Pharmaceutical Ingredients (API) Production Growth Rate (2016-2021)
3.5.2 Europe Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 China Active Pharmaceutical Ingredients (API) Production
3.6.1 China Active Pharmaceutical Ingredients (API) Production Growth Rate (2016-2021)
3.6.2 China Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Japan Active Pharmaceutical Ingredients (API) Production
3.7.1 Japan Active Pharmaceutical Ingredients (API) Production Growth Rate (2016-2021)
3.7.2 Japan Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 India Active Pharmaceutical Ingredients (API) Production
3.8.1 India Active Pharmaceutical Ingredients (API) Production Growth Rate (2016-2021)
3.8.2 India Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Active Pharmaceutical Ingredients (API) Consumption by Region
4.1 Global Active Pharmaceutical Ingredients (API) Consumption by Region
4.1.1 Global Active Pharmaceutical Ingredients (API) Consumption by Region
4.1.2 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Region
4.2 North America
4.2.1 North America Active Pharmaceutical Ingredients (API) Consumption by Country
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Active Pharmaceutical Ingredients (API) Consumption by Country
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Active Pharmaceutical Ingredients (API) Consumption by Country
4.5.2 Mexico
4.5.3 Brazil

5 Production, Revenue, Price Trend by Type
5.1 Global Active Pharmaceutical Ingredients (API) Production Market Share by Type (2016-2021)
5.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2016-2021)
5.3 Global Active Pharmaceutical Ingredients (API) Price by Type (2016-2021)

6 Consumption Analysis by Application
6.1 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2016-2021)
6.2 Global Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled
7.1 Teva
7.1.1 Teva Active Pharmaceutical Ingredients (API) Corporation Information
7.1.2 Teva Active Pharmaceutical Ingredients (API) Product Portfolio
7.1.3 Teva Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.1.4 Teva Main Business and Markets Served
7.1.5 Teva Recent Developments/Updates
7.2 Mylan
7.2.1 Mylan Active Pharmaceutical Ingredients (API) Corporation Information
7.2.2 Mylan Active Pharmaceutical Ingredients (API) Product Portfolio
7.2.3 Mylan Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.2.4 Mylan Main Business and Markets Served
7.2.5 Mylan Recent Developments/Updates
7.3 DSM
7.3.1 DSM Active Pharmaceutical Ingredients (API) Corporation Information
7.3.2 DSM Active Pharmaceutical Ingredients (API) Product Portfolio
7.3.3 DSM Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.3.4 DSM Main Business and Markets Served
7.3.5 DSM Recent Developments/Updates
7.4 Aurobindo Pharma
7.4.1 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Corporation Information
7.4.2 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Portfolio
7.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.4.4 Aurobindo Pharma Main Business and Markets Served
7.4.5 Aurobindo Pharma Recent Developments/Updates
7.5 Aspen
7.5.1 Aspen Active Pharmaceutical Ingredients (API) Corporation Information
7.5.2 Aspen Active Pharmaceutical Ingredients (API) Product Portfolio
7.5.3 Aspen Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.5.4 Aspen Main Business and Markets Served
7.5.5 Aspen Recent Developments/Updates
7.6 Novartis
7.6.1 Novartis Active Pharmaceutical Ingredients (API) Corporation Information
7.6.2 Novartis Active Pharmaceutical Ingredients (API) Product Portfolio
7.6.3 Novartis Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.6.4 Novartis Main Business and Markets Served
7.6.5 Novartis Recent Developments/Updates
7.7 BASF
7.7.1 BASF Active Pharmaceutical Ingredients (API) Corporation Information
7.7.2 BASF Active Pharmaceutical Ingredients (API) Product Portfolio
7.7.3 BASF Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.7.4 BASF Main Business and Markets Served
7.7.5 BASF Recent Developments/Updates
7.8 Pfizer
7.8.1 Pfizer Active Pharmaceutical Ingredients (API) Corporation Information
7.8.2 Pfizer Active Pharmaceutical Ingredients (API) Product Portfolio
7.8.3 Pfizer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.8.4 Pfizer Main Business and Markets Served
7.7.5 Pfizer Recent Developments/Updates
7.9 Huahai Pharmaceutical
7.9.1 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Corporation Information
7.9.2 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
7.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.9.4 Huahai Pharmaceutical Main Business and Markets Served
7.9.5 Huahai Pharmaceutical Recent Developments/Updates
7.10 Hisun Pharmaceutical
7.10.1 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Corporation Information
7.10.2 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
7.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.10.4 Hisun Pharmaceutical Main Business and Markets Served
7.10.5 Hisun Pharmaceutical Recent Developments/Updates
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Corporation Information
7.11.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Portfolio
7.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.11.4 Sun Pharmaceutical Industries Main Business and Markets Served
7.11.5 Sun Pharmaceutical Industries Recent Developments/Updates
7.12 Zhejiang Medicine
7.12.1 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Corporation Information
7.12.2 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Portfolio
7.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.12.4 Zhejiang Medicine Main Business and Markets Served
7.12.5 Zhejiang Medicine Recent Developments/Updates
7.13 Dr. Reddy’s Laboratories
7.13.1 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Corporation Information
7.13.2 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product Portfolio
7.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.13.4 Dr. Reddy’s Laboratories Main Business and Markets Served
7.13.5 Dr. Reddy’s Laboratories Recent Developments/Updates
7.14 Zhejiang NHU
7.14.1 Zhejiang NHU Active Pharmaceutical Ingredients (API) Corporation Information
7.14.2 Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Portfolio
7.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.14.4 Zhejiang NHU Main Business and Markets Served
7.14.5 Zhejiang NHU Recent Developments/Updates
7.15 Bayer
7.15.1 Bayer Active Pharmaceutical Ingredients (API) Corporation Information
7.15.2 Bayer Active Pharmaceutical Ingredients (API) Product Portfolio
7.15.3 Bayer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.15.4 Bayer Main Business and Markets Served
7.15.5 Bayer Recent Developments/Updates
7.16 NCPC
7.16.1 NCPC Active Pharmaceutical Ingredients (API) Corporation Information
7.16.2 NCPC Active Pharmaceutical Ingredients (API) Product Portfolio
7.16.3 NCPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.16.4 NCPC Main Business and Markets Served
7.16.5 NCPC Recent Developments/Updates
7.17 AbbVie
7.17.1 AbbVie Active Pharmaceutical Ingredients (API) Corporation Information
7.17.2 AbbVie Active Pharmaceutical Ingredients (API) Product Portfolio
7.17.3 AbbVie Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.17.4 AbbVie Main Business and Markets Served
7.17.5 AbbVie Recent Developments/Updates
7.18 Shandong Xinhua Pharmaceutical
7.18.1 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Corporation Information
7.18.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
7.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.18.4 Shandong Xinhua Pharmaceutical Main Business and Markets Served
7.18.5 Shandong Xinhua Pharmaceutical Recent Developments/Updates
7.19 Northeast Pharm
7.19.1 Northeast Pharm Active Pharmaceutical Ingredients (API) Corporation Information
7.19.2 Northeast Pharm Active Pharmaceutical Ingredients (API) Product Portfolio
7.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.19.4 Northeast Pharm Main Business and Markets Served
7.19.5 Northeast Pharm Recent Developments/Updates
7.20 Harbin Pharmaceutical
7.20.1 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Corporation Information
7.20.2 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
7.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.20.4 Harbin Pharmaceutical Main Business and Markets Served
7.20.5 Harbin Pharmaceutical Recent Developments/Updates
7.21 LKPC
7.21.1 LKPC Active Pharmaceutical Ingredients (API) Corporation Information
7.21.2 LKPC Active Pharmaceutical Ingredients (API) Product Portfolio
7.21.3 LKPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.21.4 LKPC Main Business and Markets Served
7.21.5 LKPC Recent Developments/Updates

8 Active Pharmaceutical Ingredients (API) Manufacturing Cost Analysis
8.1 Active Pharmaceutical Ingredients (API) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
8.4 Active Pharmaceutical Ingredients (API) Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Active Pharmaceutical Ingredients (API) Distributors List
9.3 Active Pharmaceutical Ingredients (API) Customers

10 Market Dynamics
10.1 Active Pharmaceutical Ingredients (API) Industry Trends
10.2 Active Pharmaceutical Ingredients (API) Growth Drivers
10.3 Active Pharmaceutical Ingredients (API) Market Challenges
10.4 Active Pharmaceutical Ingredients (API) Market Restraints

11 Production and Supply Forecast
11.1 Global Forecasted Production of Active Pharmaceutical Ingredients (API) by Region (2022-2027)
11.2 North America Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
11.3 Europe Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
11.4 China Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
11.5 Japan Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
11.6 India Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast
12.1 Global Forecasted Demand Analysis of Active Pharmaceutical Ingredients (API)
12.2 North America Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
12.3 Europe Market Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
12.4 Asia Pacific Market Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Region
12.5 Latin America Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country

13 Forecast by Type and by Application (2022-2027)
13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
13.1.1 Global Forecasted Production of Active Pharmaceutical Ingredients (API) by Type (2022-2027)
13.1.2 Global Forecasted Revenue of Active Pharmaceutical Ingredients (API) by Type (2022-2027)
13.1.3 Global Forecasted Price of Active Pharmaceutical Ingredients (API) by Type (2022-2027)
13.2 Global Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Application (2022-2027)

14 Research Finding and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

In Order to place the Purchase Query Click Here:
https://www.qyresearch.com/settlement/pre/4111066/global-active-pharmaceutical-ingredients-api-market

QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 218, CITY OF INDUSTRY
CA – 91748, UNITED STATES OF AMERICA
+1 626 539 9760 / +91 9766478224
hitesh@qyresearch.com / enquiry@qyresearch.com

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

This release was published on openPR.